norstella-logo-white

News & Events

Keep up with the latest news, insights and events from Norstella and its market-leading brands

News | Insights | Events

News

Press Releases | Jun. 28, 2022

Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions

June 28, 2022 – Norstella, an organization that helps life sciences companies navigate the complexities of the drug life cycle, and Citeline (formerly Pharma Intelligence)—a leading provider of specialist intelligence, data and software for clinical trials, drug development and regulatory compliance—have announced an agreement to merge the companies. Read more
Press Releases | Jun. 23, 2022

MMIT Announces Winners of the Q1 2022 Patient Access Awards

June 23, 2022, Yardley, PA – Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has launched the inaugural Patient Access Awards to honor pharmaceutical manufacturers committed to improving patient access to life-saving therapies. Read more
In the News | Jun. 22, 2022

Merger creates $5 billion pharma technology company

Norstella and Citeline (formerly Pharma Intelligence) have merged to form a $5 billion global company, one of the largest pharma intelligence solutions providers on the market. Read more
In the News | Jun. 22, 2022

Norstella, Citeline merge to create $5bn pharma tech firm

Citeline and Norstella have completed a merger, first announced in June, to create one of the largest players in the pharmaceutical intelligence category. Read more
In the News | Jun. 22, 2022

Norstella completes acquisition of Citeline to form $5B pharma intelligence group

Although financial terms weren’t disclosed, Norstella estimates that it is now a $5 billion player in the market, the company said in a Nov. 1 press release. The acquisition was first announced in June. Read more
In the News | Jun. 22, 2022

Norstella completes merger with Citeline to form $5B pharma tech company

The combined company has more than 1,500 employees worldwide, including about 200 in the Philadelphia region. Read more
In the News | Jun. 22, 2022

Citeline, Norstella complete $5B merger

Citeline and Norstella announced the completion of their $5 billion merger Tuesday morning. The deal, first announced in late June, creates one of the world’s largest pharmaceutical intelligence solutions providers. The combined company has $5 billion and 1,600 employees. Citeline will join four other brands, Evaluate, MMIT, Panalgo and The Dedham Group, as part of Norstella. Read more
Press Releases | May. 09, 2022

MMIT Announces the Winners of the Seventh-Annual Specialty Pharmacy Patient Choice Awards

May 9, 2022, Yardley, PA – Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has announced the winners of the seventh-annual Specialty Pharmacy Patient Choice Awards.  Each year, MMIT hosts the Patient Choice Awards to honor specialty pharmacies that provide best-in-class customer satisfaction and overall patient care within four categories: Payer/PBM, Hospital and Health System, Independent and Retail. Read more
Press Releases | May. 03, 2022

Four prominent pharmaceutical solutions providers launch Norstella to drive innovation and get patients access to life-saving therapies faster

May 3, 2022 – Creating a hub for rapid innovation, four prominent pharmaceutical solutions providers—Evaluate, MMIT, Panalgo and The Dedham Group—are thrilled to announce the launch of Norstella. Read more
Press Releases | Feb. 17, 2022

MMIT Announces Game-Changing Solution for Life Sciences Companies

Feb. 17, 2022, Yardley, PA – Following the acquisition of healthcare analytics company Panalgo in September 2021, Managed Markets Insight & Technology (MMIT) has announced the launch of Patient Access Analytics Read more
Press Releases | Sep. 28, 2021

MMIT/Evaluate Acquire Panalgo

MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making The move will result in a disruptive, market-leading analytics platform that provides on-demand insights across dozens of normalized real-world evidence and market access data sets that support decision-making from pipeline to prescription September 28, 2021, Yardley, PA — Managed Markets Insight & Technology (MMIT) and […] Read more
Press Releases | Aug. 20, 2021

MMIT and Evaluate

MMIT and Evaluate Join Forces to Offer an End-to-End View of the Pharmaceutical Market Landscape By combining their technology, data and expertise, MMIT and Evaluate will become a $1.6 billion global pharma commercial intelligence provider August 20, 2021, Yardley, PA — Managed Markets Insight & Technology (MMIT), LLC, the trusted go-to-market partner solely focused on solving the “what […] Read more
Press Releases | Apr. 27, 2021

MMIT & The Dedham Group Unite to Smooth Access to Therapy

The combined data, technologies and expertise of both organizations will positively impact patient access to life saving treatments April 27, 2021, Yardley, PA – Managed Markets Insight & Technology, LLC. (MMIT), the trusted go-to-market partner solely focused on solving the “what and why” of market access—so that patients don’t face delays when trying to access lifesaving […] Read more

Insights

REPORT | Jul. 30, 2021

Evaluate Pharma World Preview 2021: Outlook to 2026

Evaluate’s comprehensive report tracks the expected performance of the biopharma industry between now and 2026, based on Evaluate Pharma’s coverage of the world’s leading pharmaceutical and biotech companies. Read more
Article | Dec. 21, 2021

Market Access Speed Is the Next Critical Differentiator for Pharma Manufacturers

With the cost of healthcare and drug discovery continuing to rise and value-based contracting gaining traction, demonstrating a product’s economic value compared to existing competitor products is more important than ever. Drugs today need to be reimbursable, not just approvable, writes MMIT’s Dinesh Kabaleeswaran in an article for PharmExec. Read more
Article | Sep. 15, 2021

RWE: Supporting Regulatory Submissions with Real-World Evidence

When submitting RWE, it is crucial for life sciences organizations to not only feel confident in the data they provide, but also that it will be accepted by regulatory reviewers, writes Panalgo’s Tiffany Siu Woodworth. The main question these companies must ask themselves is, how can we trust the evidence we are providing? Read more

Events

Conference | March 2023

AMCP 2023

Meet MMIT at AMCP, San Antonio, TX, Mar 21-24, 2023. AMCP 2023 is expected to attract more than 4,000 managed care decision-makers eager to engage in immersive education sessions, thought-provoking keynote presentations, and quality networking opportunities.
Learn more
Conference | April 2023

Asembia 2023

Meet MMIT at Asembia Specialty Pharmacy Summit, Las Vegas, NV, Apr 30-May 4, 2023. Asembia’s Specialty Pharmacy Summit is at the epicenter of the pharmacy industry, providing a unique opportunity for stakeholders throughout the industry, providing a unique opportunity for stakeholders throughout the industry to understand challenges, generate solutions and define the future.
Learn more
Conference | May 2023

ISPOR 2023

Meet Panalgo at ISPOR, Boston, MA, May 7-10, 2023. ISPOR is the leading global conference for Health Economics and Outcomes Research where healthcare leaders discuss latest trends in HEOR research and healthcare trends.
Learn more

Work with us

Join our mission

We're looking for agile, growth-oriented team players who are passionate about client success and helping patients get access to the therapies they need.

Work with us

Get in Touch

Let's connect

Have questions about Norstella or its brands? Or do you want to know more about how to solve your market access challenges?

We want to hear from you